Immunology, Virology, Viral load, Internal medicine and Viral disease are his primary areas of study. His studies link Acquired immunodeficiency syndrome with Immunology. As part of one scientific family, Frederick Hecht deals mainly with the area of Virology, narrowing it down to issues related to the Chronic infection, and often CTL*.
His studies in Viral load integrate themes in fields like Prospective cohort study, Disease reservoir, Polymerase chain reaction and Intensive care medicine. His studies deal with areas such as Gastroenterology, Pill and Surgery as well as Internal medicine. His T cell study incorporates themes from Inflammation, Cytotoxic T cell, Pharmacotherapy and Antigen.
His primary scientific interests are in Immunology, Genetics, Virology, Internal medicine and Viral load. His research on Immunology frequently links to adjacent areas such as Cytotoxic T cell. Frederick Hecht combines subjects such as Epitope and RNA with his study of Virology.
His Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology. His research investigates the connection with Chromosome and areas like Chromosomal translocation which intersect with concerns in Karyotype, Cytogenetics, Molecular biology, Leukemia and Cancer research. He is interested in Lentivirus, which is a field of Viral disease.
The scientist’s investigation covers issues in Immunology, Virology, Viral load, Randomized controlled trial and Internal medicine. His Immunology study frequently draws connections between related disciplines such as Cytotoxic T cell. His research investigates the connection between Virology and topics such as RNA that intersect with issues in Transcription.
His Viral load study integrates concerns from other disciplines, such as Cellular immunity, Human leukocyte antigen, Disease and Antiretroviral therapy. Frederick Hecht has researched Randomized controlled trial in several fields, including Weight loss, Overweight, Physical therapy, Mindfulness and Type 2 diabetes. His biological study spans a wide range of topics, including Diabetes mellitus, Endocrinology, Gastroenterology and Oncology.
His primary areas of investigation include Immunology, Virology, Viral load, T cell and Internal medicine. The study incorporates disciplines such as Cytotoxic T cell and CD38 in addition to Immunology. His study in Virology focuses on Viral replication in particular.
His Viral load research incorporates themes from Chronic infection, Viremia, Drug holiday and Disease. His T cell research is multidisciplinary, incorporating perspectives in Immune checkpoint, Inflammation, Antigen, Interleukin 2 and Antibody. The Virus study combines topics in areas such as Transmission and Acquired immunodeficiency syndrome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher.
Nature Medicine (2006)
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.
David R. Bangsberg;Frederick M. Hecht;Edwin D. Charlebois;Andrew R. Zolopa.
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.
Steven G. Deeks;Christina M. R. Kitchen;Lea Liu;Hua Guo.
New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes
Robert S. Janssen;Glen A. Satten;Susan L. Stramer;Bhupat D. Rawal.
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R. Brad Jones;Lishomwa C Ndhlovu;Jason D. Barbour;Prameet M. Sheth.
Journal of Experimental Medicine (2008)
Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens
Einar M. Aandahl;Jakob Michaëlsson;Walter J. Moretto;Frederick M. Hecht.
Journal of Virology (2004)
Time trends in primary HIV-1 drug resistance among recently infected persons.
Robert M. Grant;Frederick M. Hecht;Maria Warmerdam;Lea Liu.
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.
Frederick M. Hecht;Robert M. Grant;Christos J. Petropoulos;Beth Dillon.
The New England Journal of Medicine (1998)
Body awareness: construct and self-report measures.
Wolf E. Mehling;Viranjini Gopisetty;Jennifer Daubenmier;Cynthia J. Price.
PLOS ONE (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: